HC Wainwright maintains PMV Pharmaceuticals $5.00 price target
HC Wainwright & Co. maintained its price target for PMV Pharmaceuticals at $5.00 per share,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.